Cost -rising Medicine's gross profit margin is difficult to continue to rise
Release time: 2010-04-08 & nbsp & nbsp & nbsp Source:
According to Wind statistics,As of March 18,135 pharmaceutical listed companies have 41 disclosure of the 2009 annual report。The average gross profit margin of this 41 company in 2009 increased from 43.57%in 2008 to 45.65%。The average gross profit margin of nearly 500 listed companies that have been disclosed in the annual report increases less than one percentage point than 2008。
Analysts think,This is directly related to the low cost of various raw materials in the pharmaceutical My stake betting appstake sports betting appindustry in the first half of last year last year,But this year's drought weather will lead to rising raw material prices,Plus the bidding and procurement of drugs and cities in various provinces and cities may lead to a slight decline in drug prices,It is expected that the gross profit margin of the pharmaceutical industry will have a steady and downward gross profit margin this year。
Multiple factors thickened gross profit margin
Analysts said,In the first half of 2009,Due to the decline in the price of raw materials caused by the international financial crisis, it has benefited from Pharmaceutical Enterprise。In addition,VE and other raw drug prices after the plunge of 2008,A sharp rise in 2009,It has also promoted the increase in the gross profit margin of related raw and drug companies。
Statistics display,These 41 pharmaceutical listed companies realized the main business revenue in 2009 for a total of 60.645 billion yuan,increased by 17.8%from 51.475 billion yuan in 2008,and the cost of business in 2009 a total of 35.469 billion yuan,Compared with 31.95 billion yuan in 2008, it only increased 11%。
In the pharmaceutical sub -industry,The gross profit margin increase in the biological product industry is the most significant。7 biological products listed companies that announce annual reports My stake betting apphave stake betting appincreased the average gross profit margin from 41.3%in 2008 to 46%。Hualan's biological gross profit margin increased from 60%to 76%in a year,increased by 16 percentage points。Company Annual Report Display,The rising gross profit margin is mainly due to the significant increase in the proportion of vaccine accounts,2009 The H1N1 influenza epidemic in 2009 indirectly helps the company's gross profit increase。In the company's products,The operating profit margin of the flu vaccine is 84.82%,increased by 17.54 percentage points year -on -year,The operating profit margin of blood products increased by 4.88 percentage points year -on -year,The operating profit margin of human blood albumin increased by 5.79 percentage points。In addition,Due to the company's product supply in short supply,Product prices have risen year -on -year。
The gross margin in the Chinese medicine industry increased from 65%in 2008 to 76%。Company Annual Report Display,In the company's main business,The gross profit margin of Pharmaceutical is 12.44%,increased by about 8 percentage points year -on -year。
This year or steadily drop
The price of raw materials appeared in the second half of 2009,and many listed companies have expected the pressure on the cost of raw materials this year。Wohua Pharmaceutical said in the annual report,stake sports betting appStake Sports BettingFacing raw materials in 2010、The rise in energy prices and the increase in labor costs,Cost pressure increases,Therefore, the company will further enhance the control of cost。
and for Hualan Bio，Analysts think,Last year, the gross profit margin increased greatly because the company responded to the large number of vaccine business in the company's response to the A flow epidemic，and this situation is difficult to continue in 2010。
Researcher researcher in the Southwest Securities Industry believes，Drought weather in Southwest China earlier this year makes the price of traditional Chinese medicine raw materials rising expected,This will put pressure on the increase in the gross profit margin of Chinese medicine companies。
Researcher of Guomu Securities Industry said，Although the possibility of a significant decline in drug prices in the bidding of drugs in various provinces is not much high，But it does not rule out the price of some low -end generic drugs to drop again。In addition，For the material drug company，Prices have increased significantly last year，The possibility of repeating the upsurge this year is not much likely。Under the common action of a variety of factors，The gross profit margin of this year's pharmaceutical industry is significantly increasing.My stake betting appstake online sports betting，The most likely situation is that it is stable and down。
Analysts think,This is directly related to the low cost of various raw materials in the pharmaceutical My stake betting appstake sports betting appindustry in the first half of last year last year,But this year's drought weather will lead to rising raw material prices,Plus the bidding and procurement of drugs and cities in various provinces and cities may lead to a slight decline in drug prices,It is expected that the gross profit margin of the pharmaceutical industry will have a steady and downward gross profit margin this year。
Multiple factors thickened gross profit margin
Analysts said,In the first half of 2009,Due to the decline in the price of raw materials caused by the international financial crisis, it has benefited from Pharmaceutical Enterprise。In addition,VE and other raw drug prices after the plunge of 2008,A sharp rise in 2009,It has also promoted the increase in the gross profit margin of related raw and drug companies。
Statistics display,These 41 pharmaceutical listed companies realized the main business revenue in 2009 for a total of 60.645 billion yuan,increased by 17.8%from 51.475 billion yuan in 2008,and the cost of business in 2009 a total of 35.469 billion yuan,Compared with 31.95 billion yuan in 2008, it only increased 11%。
In the pharmaceutical sub -industry,The gross profit margin increase in the biological product industry is the most significant。7 biological products listed companies that announce annual reports My stake betting apphave stake betting appincreased the average gross profit margin from 41.3%in 2008 to 46%。Hualan's biological gross profit margin increased from 60%to 76%in a year,increased by 16 percentage points。Company Annual Report Display,The rising gross profit margin is mainly due to the significant increase in the proportion of vaccine accounts,2009 The H1N1 influenza epidemic in 2009 indirectly helps the company's gross profit increase。In the company's products,The operating profit margin of the flu vaccine is 84.82%,increased by 17.54 percentage points year -on -year,The operating profit margin of blood products increased by 4.88 percentage points year -on -year,The operating profit margin of human blood albumin increased by 5.79 percentage points。In addition,Due to the company's product supply in short supply,Product prices have risen year -on -year。
The gross margin in the Chinese medicine industry increased from 65%in 2008 to 76%。Company Annual Report Display,In the company's main business,The gross profit margin of Pharmaceutical is 12.44%,increased by about 8 percentage points year -on -year。
This year or steadily drop
The price of raw materials appeared in the second half of 2009,and many listed companies have expected the pressure on the cost of raw materials this year。Wohua Pharmaceutical said in the annual report,stake sports betting appStake Sports BettingFacing raw materials in 2010、The rise in energy prices and the increase in labor costs,Cost pressure increases,Therefore, the company will further enhance the control of cost。
and for Hualan Bio，Analysts think,Last year, the gross profit margin increased greatly because the company responded to the large number of vaccine business in the company's response to the A flow epidemic，and this situation is difficult to continue in 2010。
Researcher researcher in the Southwest Securities Industry believes，Drought weather in Southwest China earlier this year makes the price of traditional Chinese medicine raw materials rising expected,This will put pressure on the increase in the gross profit margin of Chinese medicine companies。
Researcher of Guomu Securities Industry said，Although the possibility of a significant decline in drug prices in the bidding of drugs in various provinces is not much high，But it does not rule out the price of some low -end generic drugs to drop again。In addition，For the material drug company，Prices have increased significantly last year，The possibility of repeating the upsurge this year is not much likely。Under the common action of a variety of factors，The gross profit margin of this year's pharmaceutical industry is significantly increasing.My stake betting appstake online sports betting，The most likely situation is that it is stable and down。
